297 related articles for article (PubMed ID: 9620988)
1. In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor.
Nagashunmugam T; Lubinski J; Wang L; Goldstein LT; Weeks BS; Sundaresan P; Kang EH; Dubin G; Friedman HM
J Virol; 1998 Jul; 72(7):5351-9. PubMed ID: 9620988
[TBL] [Abstract][Full Text] [Related]
2. The herpes simplex virus 1 IgG fc receptor blocks antibody-mediated complement activation and antibody-dependent cellular cytotoxicity in vivo.
Lubinski JM; Lazear HM; Awasthi S; Wang F; Friedman HM
J Virol; 2011 Apr; 85(7):3239-49. PubMed ID: 21228231
[TBL] [Abstract][Full Text] [Related]
3. Immunization strategies to block the herpes simplex virus type 1 immunoglobulin G Fc receptor.
Lin X; Lubinski JM; Friedman HM
J Virol; 2004 Mar; 78(5):2562-71. PubMed ID: 14963159
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells.
Dingwell KS; Brunetti CR; Hendricks RL; Tang Q; Tang M; Rainbow AJ; Johnson DC
J Virol; 1994 Feb; 68(2):834-45. PubMed ID: 8289387
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus type 1 evades the effects of antibody and complement in vivo.
Lubinski JM; Jiang M; Hook L; Chang Y; Sarver C; Mastellos D; Lambris JD; Cohen GH; Eisenberg RJ; Friedman HM
J Virol; 2002 Sep; 76(18):9232-41. PubMed ID: 12186907
[TBL] [Abstract][Full Text] [Related]
6. The herpes simplex virus-1 glycoprotein E (gE) mediates IgG binding and cell-to-cell spread through distinct gE domains.
Weeks BS; Sundaresan P; Nagashunmugam T; Kang E; Friedman HM
Biochem Biophys Res Commun; 1997 Jun; 235(1):31-5. PubMed ID: 9196030
[TBL] [Abstract][Full Text] [Related]
7. Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E.
Hook LM; Huang J; Jiang M; Hodinka R; Friedman HM
J Virol; 2008 Jul; 82(14):6935-41. PubMed ID: 18480440
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus type 1 glycoprotein E domains involved in virus spread and disease.
Saldanha CE; Lubinski J; Martin C; Nagashunmugam T; Wang L; van Der Keyl H; Tal-Singer R; Friedman HM
J Virol; 2000 Aug; 74(15):6712-9. PubMed ID: 10888608
[TBL] [Abstract][Full Text] [Related]
9. Immune evasion by herpes simplex virus type 1, strategies for virus survival.
Friedman HM
Trans Am Clin Climatol Assoc; 2003; 114():103-12. PubMed ID: 12813914
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI.
Johnson DC; Frame MC; Ligas MW; Cross AM; Stow ND
J Virol; 1988 Apr; 62(4):1347-54. PubMed ID: 2831396
[TBL] [Abstract][Full Text] [Related]
11. The herpes virus Fc receptor gE-gI mediates antibody bipolar bridging to clear viral antigens from the cell surface.
Ndjamen B; Farley AH; Lee T; Fraser SE; Bjorkman PJ
PLoS Pathog; 2014 Mar; 10(3):e1003961. PubMed ID: 24604090
[TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus IgG Fc receptors induced using recombinant adenovirus vectors expressing glycoproteins E and I.
Hanke T; Graham FL; Lulitanond V; Johnson DC
Virology; 1990 Aug; 177(2):437-44. PubMed ID: 2164721
[TBL] [Abstract][Full Text] [Related]
13. Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine.
Awasthi S; Lubinski JM; Friedman HM
Vaccine; 2009 Nov; 27(49):6845-53. PubMed ID: 19761834
[TBL] [Abstract][Full Text] [Related]
14. Characterization of domains of herpes simplex virus type 1 glycoprotein E involved in Fc binding activity for immunoglobulin G aggregates.
Dubin G; Basu S; Mallory DL; Basu M; Tal-Singer R; Friedman HM
J Virol; 1994 Apr; 68(4):2478-85. PubMed ID: 7511171
[TBL] [Abstract][Full Text] [Related]
15. Viral interference with antibody and complement.
Lubinski J; Nagashunmugam T; Friedman HM
Semin Cell Dev Biol; 1998 Jun; 9(3):329-37. PubMed ID: 9665870
[TBL] [Abstract][Full Text] [Related]
16. Glycoproteins E and I facilitate neuron-to-neuron spread of herpes simplex virus.
Dingwell KS; Doering LC; Johnson DC
J Virol; 1995 Nov; 69(11):7087-98. PubMed ID: 7474128
[TBL] [Abstract][Full Text] [Related]
17. Glycoprotein C of Herpes Simplex Virus 1 Shields Glycoprotein B from Antibody Neutralization.
Komala Sari T; Gianopulos KA; Nicola AV
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826995
[TBL] [Abstract][Full Text] [Related]
18. Antibody-mediated protection against genital herpes simplex virus type 2 disease in mice by Fc gamma receptor-dependent and -independent mechanisms.
Chu CF; Meador MG; Young CG; Strasser JE; Bourne N; Milligan GN
J Reprod Immunol; 2008 Jun; 78(1):58-67. PubMed ID: 17950908
[TBL] [Abstract][Full Text] [Related]
19. Responses of herpes simplex virus type 1-infected cells to the presence of extracellular antibodies: gE-dependent glycoprotein capping and enhancement in cell-to-cell spread.
Rizvi SM; Raghavan M
J Virol; 2003 Jan; 77(1):701-8. PubMed ID: 12477873
[TBL] [Abstract][Full Text] [Related]
20. UL13 protein kinase of herpes simplex virus 1 complexes with glycoprotein E and mediates the phosphorylation of the viral Fc receptor: glycoproteins E and I.
Ng TI; Ogle WO; Roizman B
Virology; 1998 Feb; 241(1):37-48. PubMed ID: 9454715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
